Selected publications
-
Distinctive clinical presentation of a NF-1 patient with loss of heterozygosity of PTCH in his epithelial tumors.
International journal of dermatology.
2005
Academic Article
GET IT
Times cited: 0 -
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
The Journal of infectious diseases.
2005
Academic Article
GET IT
Times cited: 14 -
Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
Archives of dermatology.
2004
Academic Article
GET IT
Times cited: 10 -
In vivo assessment of antiviral reactivity in chronic HIV infection.
HIV clinical trials.
2000
Academic Article
GET IT
Times cited: 12 -
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial.
HIV clinical trials.
2000
Academic Article
GET IT
Times cited: 46 -
Immunity restoration of immunity with interleukin-2 therapy.
The AIDS reader.
1999
Academic Article
Times cited: 8 -
Interleukin-2 infusions in HIV-infected patients.
The New England journal of medicine.
1997
Comment
GET IT
Times cited: 5 -
Interleukin-2 therapy for HIV* individuals.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
1996
Academic Article
Times cited: 0 -
Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.
Proceedings of the National Academy of Sciences of the United States of America.
1996
Academic Article
GET IT
Times cited: 155